articleTop 1% cited
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study
Journal of Hypertension · 2009 · Vol. 27(7) · pp. 1360–1369
Peter Sleight✉(John Radcliffe Hospital)Josep Redón(Universitat de València)Paolo Verdecchia(Misericordia University)Giuseppe Mancia(IRCCS Istituto Auxologico Italiano)Peggy Gao(McMaster University)Robert Fagard(KU Leuven)Helmut Schumacher(Boehringer Ingelheim (Egypt))Michael A. Weber(SUNY Downstate Health Sciences University)Michael Böhm(Saarland University)Bryan Williams(University of Leicester)Janice Pogue(McMaster University)Koon Teo(McMaster University)Salim Yusuf(McMaster University)
Abstract
In high-risk patients, the benefits from SBP lowering below 130 mmHg are driven mostly by a reduction of stroke; myocardial infarction is unaffected and cardiovascular mortality is unchanged or increased. Future trials should be designed to test the value of SBP lowering in high-risk patients with SBP in the range of 130-150 mmHg.
Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionHormonal Regulation and HypertensionMedicineRamiprilTelmisartanBlood pressureInternal medicineMyocardial infarctionStroke (engine)CardiologyDiabetes mellitusClinical endpoint
MeSH terms
TelmisartanAgedAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBenzimidazolesBenzoatesBlood PressureDouble-Blind MethodFemaleHumansHypertensionMaleMiddle AgedPrognosisTreatment Outcome
Citations
351
FWCI
30.67
field-weighted impact
References
24
Percentile
100%
vs. same field & year
Citations per year
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
European Heart Journal · 2018 · 10,258 citations
2018 ESC/ESH Guidelines for the management of arterial hypertension
Journal of Hypertension · 2018 · 2,790 citations
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
The Journal of Clinical Endocrinology & Metabolism · 2012 · 1,439 citations
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
Heart · 2014 · 609 citations
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Journal of Hypertension · 2009 · 1,655 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal · 2013 · 13,652 citations
Standards of Medical Care in Diabetes—2014
Diabetes Care · 2013 · 4,552 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
Journal of Hypertension · 2013 · 5,659 citations
References
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
The Lancet · 2002 · 10,173 citations
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension
Journal of Hypertension · 2007 · 1,838 citations
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
Journal of Hypertension · 2005 · 387 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal · 2013 · 13,652 citations
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
The Lancet · 1998 · 5,769 citations
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Hypertension · 2003 · 13,237 citations
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
JAMA · 2003 · 25,504 citations
2007 Guidelines for the Management of Arterial Hypertension
Journal of Hypertension · 2007 · 5,830 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.